Reliability and Usefulness of ChatGPT for Inflammatory Bowel Diseases: An Analysis for Patients and Healthcare Professionals

被引:14
|
作者
Cankurtaran, Rasim Eren [1 ]
Polat, Yunus Halil [2 ]
Aydemir, Neslihan Gunes [3 ]
Umay, Ebru [4 ]
Yurekli, Oyku Tayfur [5 ]
机构
[1] Ankara Etlik City Hosp, Dept Perinatol, Ankara, Turkiye
[2] Ankara Numune Training & Res Hosp, Dept Gastroenterol, Ankara, Turkiye
[3] Akdeniz Univ, Fac Med, Dept Gastroenterol, Antalya, Turkiye
[4] Univ Hlth Sci, Ankara Etlik City Hosp, Phys Med & Rehabil, Ankara, Turkiye
[5] Ankara Yildirim Beyazit Univ, Fac Med, Dept Gastroenterol, Ankara, Turkiye
关键词
ulcerative colitis (uc); crohn's disease (cd); healthcare research; artificial intelligence (ai); inflammatory; bowel diseases (ibd); large language model; chatgpt;
D O I
10.7759/cureus.46736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: We aimed to evaluate the performance of Chat Generative Pre-trained Transformer (ChatGPT) within the context of inflammatory bowel disease (IBD), which is expected to become an increasingly significant health issue in the future. In addition, the objective of the study was to assess whether ChatGPT serves as a reliable and useful resource for both patients and healthcare professionals.Methods: For this study, 20 specific questions were identified for the two main components of IBD, which are Crohn's disease (CD) and ulcerative colitis (UC). The questions were divided into two sets: one set contained questions directed at healthcare professionals while the second set contained questions directed toward patients. The responses were evaluated with seven-point Likert-type reliability and usefulness scales.Results: The distribution of the reliability and utility scores was calculated into four groups (two diseases and two question sources) by averaging the mean scores from both raters. The highest scores in both reliability and usefulness were obtained from professional sources (5.00 +/- 1.21 and 5.15 +/- 1.08, respectively). The ranking in terms of reliability and usefulness, respectively, was as follows: CD questions (4.70 +/- 1.26 and 4.75 +/- 1.06) and UC questions (4.40 +/- 1.21 and 4.55 +/- 1.31). The reliability scores of the answers for the professionals were significantly higher than those for the patients (both raters, p=0.032).Conclusion: Despite its capacity for reliability and usefulness in the context of IBD, ChatGPT still has some limitations and deficiencies. The correction of ChatGPT's deficiencies and its enhancement by developers with more detailed and up-to-date information could make it a significant source of information for both patients and medical professionals.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Bone Health in Patients With Inflammatory Bowel Diseases
    Chedid, Victor G.
    Kane, Sunanda, V
    JOURNAL OF CLINICAL DENSITOMETRY, 2020, 23 (02) : 182 - 189
  • [42] Screening for spondyloarthritis in patients with inflammatory bowel diseases
    Sébastien Ottaviani
    Xavier Tréton
    Marine Forien
    Romain Coralli
    Astrid Dauchez
    Carmen Stefanescu
    Anne-Laure Pelletier
    Hakim Becheur
    Esther Ebstein
    Yoram Bouhnik
    Philippe Dieudé
    Rheumatology International, 2023, 43 : 109 - 117
  • [43] Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
    Marafini, Irene
    Monteleone, Giovanni
    BIOLOGICS-TARGETS & THERAPY, 2020, 14 : 47 - 51
  • [44] Intestinal superinfections in patients with inflammatory bowel diseases
    Antonelli, Elisabetta
    Baldoni, Monia
    Giovenali, Paolo
    Villanacci, Vincenzo
    Essatari, Murad
    Bassotti, Gabrio
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (02): : 154 - 159
  • [45] Causal attributions of patients with inflammatory bowel diseases
    Fliege, H
    Drandarevski, A
    Klapp, BF
    Rose, M
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2003, 32 (04): : 276 - 285
  • [46] Use of methotrexate in patients with inflammatory bowel diseases
    Preiss, J. C.
    Zeitz, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S151 - S155
  • [47] Functional and inflammatory bowel diseases in patients with COPD
    Berdyugina, Antonina
    Klester, Karolina
    Klester, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [48] The burden of anaemia in patients with inflammatory bowel diseases
    Testa, Anna
    Rispo, Antonio
    Romano, Marco
    Riegler, Gabriele
    Selvaggi, Francesco
    Bottiglieri, Erminia
    Martorano, Marco
    Rea, Matilde
    Gravina, Antonietta
    Nardone, Olga Maria
    Patturelli, Marta
    Pellino, Gianluca
    Miranda, Agnese
    Caporaso, Nicola
    Castiglione, Fabiana
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (03) : 267 - 270
  • [49] ROLE OF CHEMERIN IN THE PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Sochal, Marcin
    Fichna, Jakub
    Bialasiewicz, Piotr
    Talar-Wojnarowska, Renata
    Gabryelska, Agata
    Malecka-Panas, Ewa
    GASTROENTEROLOGY, 2021, 160 (03) : S18 - S18
  • [50] Osteoporosis and Osteopenia in Patients with Inflammatory Bowel Diseases
    Bodryagina, Evgenia Sergeevna
    Abdulganieva, Diana Ildarovna
    Odintsova, Alfia Kharisovna
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S87 - S87